We are live on ! Find out more
ORGO icon

Organogenesis Holdings

40 hedge funds and large institutions have $12.5M invested in Organogenesis Holdings in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 3

29% more funds holding

Funds holding: 3140 (+9)

25% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 8

6% more capital invested

Capital invested by funds: $11.8M → $12.5M (+$729K)

0.27% more ownership

Funds ownership: 1.74%2.01% (+0.27%)

Holders
40
Holders Change
+9
Holders Change %
+29.03%
% of All Funds
0.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
10
Reduced
8
Closed
3
Calls
Puts
Net Calls
Net Calls Change

ORGO Hedge Fund Activity: Q3 2019 in Review

40 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q3 2019, worth a combined $12.5M — up 6.2% from $11.8M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ORGO positions and 3 closed out — a net gain of 9 holders — while 10 added to existing stakes and 8 trimmed.

The largest buyer was Angelo Gordon & Co, opening a new position worth an estimated $825K. The largest seller was Charles Schwab, cutting an estimated $153K.

  • 40 institutional investors held Organogenesis Holdings (ORGO) as of Q3 2019, up from 31 in Q2 2019.
  • Funds reported $12.5M of Organogenesis Holdings stock for Q3 2019, up 6.2% quarter-over-quarter.
  • 12 funds opened new Organogenesis Holdings positions in Q3 2019 and 3 closed out, a net change of +9 holders.
  • The largest Organogenesis Holdings buyer in Q3 2019 was Angelo Gordon & Co, an estimated $825K added.
  • The largest Organogenesis Holdings seller in Q3 2019 was Charles Schwab, an estimated $153K sold.

Based on aggregated 13F filings for Q3 2019.